Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Farez MF, Correale J, Armstrong MJ, Rae-Grant A, Gloss D, Donley D, Holler-Managan Y, Kachuck NJ, Jeffery D, Beilman M, Gronseth G, Michelson D, Lee E, Cox J, Getchius T, Sejvar J, Narayanaswami P.

Neurology. 2019 Sep 24;93(13):584-594. doi: 10.1212/WNL.0000000000008157. Epub 2019 Aug 28.

PMID:
31462584
2.

Adaptation and validation of a Spanish version of the treatment burden questionnaire in patients with multiple sclerosis.

Ysrraelit MC, Fiol MP, Peña FV, Vanotti S, Terrasa SA, Tran VT, Montori VM, Correale J.

BMC Neurol. 2019 Aug 27;19(1):209. doi: 10.1186/s12883-019-1441-0.

3.

Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis.

Bove R, Rankin K, Lin C, Zhao C, Correale J, Hellwig K, Michel L, Laplaud DA, Chitnis T.

Mult Scler. 2019 Aug 1:1352458519865118. doi: 10.1177/1352458519865118. [Epub ahead of print]

PMID:
31368394
4.

Ontogenetic oligodendrocyte maturation through gestational iron deprivation: The road not taken.

Guitart ME, Vence M, Correale J, Pasquini JM, Rosato-Siri MV.

Glia. 2019 Sep;67(9):1760-1774. doi: 10.1002/glia.23647. Epub 2019 Jun 4.

PMID:
31162719
5.

Multiple Sclerosis Misdiagnosis: A Persistent Problem to Solve.

Gaitán MI, Correale J.

Front Neurol. 2019 May 7;10:466. doi: 10.3389/fneur.2019.00466. eCollection 2019. No abstract available.

6.

The Argentinean multiple sclerosis registry (RelevarEM): Methodological aspects and directions.

Rojas JI, Carrá A, Correale J, Cristiano E, Fernández Liguori N, Alonso R, Alvez Pinheiro A, Balbuena ME, Barboza AG, Bestoso S, Blaya PA, Burgos M, Cabrera LM, Caride A, Carnero Contentti E, Cohen L, Curbelo C, Deri N, Divi P, Fiol M, Fracaro ME, Gaitán MI, Hryb J, Jacobo M, Knorre E, Leguizamon F, Giunta D, Alonso Serena M, Doldan ML, De Lio GF, Liwacki SDV, Lopez PA, Luetic G, Mainella C, Manzi R, Marrodan M, Martinez AD, Miguez J, Negrotto L, Nofal P, Parada Marcilla M, Pettinicchi JP, Silva BA, Silva E, Silveira F, Steinberg JD, Tavolini D, Tizio S, Tkachuk V, Vazquez G, Volman G, Vrech C, Ysrraelit MC, Zanga G, Garcea O, Patrucco L.

Mult Scler Relat Disord. 2019 Jul;32:133-137. doi: 10.1016/j.msard.2019.05.004. Epub 2019 May 15.

PMID:
31128521
7.

Video head impulse test contributes to Susac syndrome diagnosis.

Marrodan M, Laffue A, Fiol MP, Correale J, Gualtieri F.

J Neurol. 2019 Aug;266(8):2070-2072. doi: 10.1007/s00415-019-09357-2. Epub 2019 May 7. No abstract available.

PMID:
31065784
8.

Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis.

Correale J, Marrodan M, Ysrraelit MC.

Biomedicines. 2019 Feb 20;7(1). pii: E14. doi: 10.3390/biomedicines7010014. Review.

9.

Transferrin Enhances Microglial Phagocytic Capacity.

Carden TR, Correale J, Pasquini JM, Pérez MJ.

Mol Neurobiol. 2019 Sep;56(9):6324-6340. doi: 10.1007/s12035-019-1519-0. Epub 2019 Feb 13.

PMID:
30758712
10.

The role of infections in multiple sclerosis.

Marrodan M, Alessandro L, Farez MF, Correale J.

Mult Scler. 2019 Jun;25(7):891-901. doi: 10.1177/1352458518823940. Epub 2019 Jan 14.

PMID:
30638421
11.

Palmar pustular psoriasis associated with teriflunomide treatment.

Negrotto L, Correale J.

Mult Scler Relat Disord. 2019 Jan;27:400-402. doi: 10.1016/j.msard.2018.11.020. Epub 2018 Nov 19.

PMID:
30513502
12.

Microglial modulation through colony-stimulating factor-1 receptor inhibition attenuates demyelination.

Wies Mancini VSB, Pasquini JM, Correale JD, Pasquini LA.

Glia. 2019 Feb;67(2):291-308. doi: 10.1002/glia.23540. Epub 2018 Nov 19.

PMID:
30456797
13.

Clinical and imaging features distinguishing Susac syndrome from primary angiitis of the central nervous system.

Marrodan M, Acosta JN, Alessandro L, Fernandez VC, Carnero Contentti E, Arakaki N, Kohler AA, Fiol MP, Ameriso SF, Correale J.

J Neurol Sci. 2018 Dec 15;395:29-34. doi: 10.1016/j.jns.2018.09.029. Epub 2018 Sep 26.

PMID:
30273791
14.

Impact of sex hormones on immune function and multiple sclerosis development.

Ysrraelit MC, Correale J.

Immunology. 2019 Jan;156(1):9-22. doi: 10.1111/imm.13004. Epub 2018 Oct 11. Review.

PMID:
30222193
15.

Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.

Bensi C, Marrodan M, González A, Chertcoff A, Osa Sanz E, Chaves H, Schteinschnaider A, Correale J, Farez MF.

Mult Scler Relat Disord. 2018 Oct;25:246-250. doi: 10.1016/j.msard.2018.08.008. Epub 2018 Aug 9.

PMID:
30144694
16.

Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America.

Cristiano E, Rojas JI, Abad P, Adoni T, Barahona J, Becker J, Carrá A, Flores J, Fruns M, Fernández Liguori N, Garcea O, García Bónito J, Giunta D, Gracia F, Hamuy F, Macias Islas MA, Navas C, Boschetti LO, Patrucco L, Sato DK, Correale J.

J Neurol Sci. 2018 Oct 15;393:4-13. doi: 10.1016/j.jns.2018.07.024. Epub 2018 Jul 31.

PMID:
30096568
17.

Effects of Systolic Blood Pressure on Brain Integrity in Multiple Sclerosis.

Dossi DE, Chaves H, Heck ES, Rodriguez Murúa S, Ventrice F, Bakshi R, Quintana FJ, Correale J, Farez MF.

Front Neurol. 2018 Jun 25;9:487. doi: 10.3389/fneur.2018.00487. eCollection 2018.

18.

Metabolic coupling of axons and glial cells: Implications for multiple sclerosis progression.

Correale J, Ysrraelit MC, Benarroch EE.

Neurology. 2018 Apr 17;90(16):737-744. doi: 10.1212/WNL.0000000000005339. Epub 2018 Mar 21. No abstract available.

PMID:
29661892
19.

New fungal infections associated with disease-modifying treatments in MS.

Correale J.

Mult Scler. 2018 Jun;24(7):1004-1006. doi: 10.1177/1352458518770090. Epub 2018 Apr 13. No abstract available.

PMID:
29649933
20.

Evolution of multiple sclerosis prevalence and phenotype in Latin America.

Negrotto L, Correale J.

Mult Scler Relat Disord. 2018 May;22:97-102. doi: 10.1016/j.msard.2018.03.014. Epub 2018 Mar 21. Review.

PMID:
29649790
21.

Corrigendum to "Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients" [J. Neurol. Sci. 385C (2018) 217-224].

Cristiano E, Alonso R, Alvez Pinheiro A, Bacile EA, Balbuena ME, Ballario C, Barboza AG, Bestoso S, Burgos M, Cáceres F, Carnero Contentti E, Carrá A, Crespo E, Curbelo MC, Deri N, Fernandez J, Fernández Liguori N, Fiol M, Gaitán MI, Garcea O, Giunta D, Halfon MJ, Hryb JP, Jacobo M, Kohler E, Linares R, Luetic GG, Martínez AD, Míguez J, Nofal PG, Patrucco L, Piedrabuena R, Rojas JI, Rotta Escalante R, Saladino ML, Silva BA, Sinay V, Steinberg JD, Tarulla A, Vétere SA, Villa A, Vrech C, Ysrraelit MC, Correale J.

J Neurol Sci. 2018 Apr 15;387:231-232. doi: 10.1016/j.jns.2018.02.003. Epub 2018 Feb 12. No abstract available.

PMID:
29449007
22.

Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients.

Cristiano E, Alonso R, Alvez Pinheiro A, Bacile EA, Balbuena ME, Ballario C, Barboza AG, Bestoso S, Burgos M, Cáceres F, Carnero Contentti E, Carrá A, Crespo E, Curbelo MC, Deri N, Fernandez J, Fernández Liguori N, Fiol M, Gaitán MI, Garcea O, Giunta D, Halfon MJ, Hryb JP, Jacobo M, Kohler E, Linares R, Luetic GG, Martínez AD, Míguez J, Nofal PG, Patrucco L, Piedrabuena R, Rojas JI, Rotta Escalante R, Saladino ML, Silva BA, Sinay V, Steinberg JD, Tarulla A, Vétere SA, Villa A, Vrech C, Ysrraelit MC, Correale J.

J Neurol Sci. 2018 Feb 15;385:217-224. doi: 10.1016/j.jns.2018.01.004. Epub 2018 Jan 4. Review. Erratum in: J Neurol Sci. 2018 Feb 12;:.

PMID:
29406907
23.

Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists.

Ysrraelit MC, Fiol MP, Gaitán MI, Correale J.

Front Neurol. 2018 Jan 11;8:729. doi: 10.3389/fneur.2017.00729. eCollection 2017.

24.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA.

Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Review.

PMID:
29275977
25.

Follow-on products for treatment of multiple sclerosis in Latin America: An update.

Correale J.

J Neurol Sci. 2017 Oct 15;381:153-159. doi: 10.1016/j.jns.2017.08.3242. Epub 2017 Aug 24. Review.

PMID:
28991670
26.

The challenges and opportunities of multiple sclerosis care in Latin America.

Ontaneda D, Correale J.

Mult Scler J Exp Transl Clin. 2017 Sep 25;3(3):2055217317720845. doi: 10.1177/2055217317720845. eCollection 2017 Jul-Sep. No abstract available.

27.

Gastrointestinal compromise in Susac Syndrome.

Marrodan M, Correale J, Alessandro L, Arakaki N, Rennebohm R, Kohler AA, Fiol MP.

J Neurol Sci. 2017 Aug 15;379:318-320. doi: 10.1016/j.jns.2017.06.040. Epub 2017 Jun 27. No abstract available.

PMID:
28716271
28.

Neutropenia in Patients With Multiple Sclerosis Treated With Alemtuzumab.

Gaitán MI, Ysrraelit MC, Correale J.

JAMA Neurol. 2017 Sep 1;74(9):1143-1144. doi: 10.1001/jamaneurol.2017.1456. No abstract available.

PMID:
28715536
29.

Susac Syndrome: A differential diagnosis of white matter lesions.

Marrodan M, Correale J, Alessandro L, Amaya M, Fracaro ME, Köhler AA, Fiol M.

Mult Scler Relat Disord. 2017 Jul;15:42-46. doi: 10.1016/j.msard.2017.04.007. Epub 2017 May 3.

PMID:
28641772
30.

Environmental factors influencing multiple sclerosis in Latin America.

Correale J, Farez MF, Gaitán MI.

Mult Scler J Exp Transl Clin. 2017 Jun 13;3(2):2055217317715049. doi: 10.1177/2055217317715049. eCollection 2017 Apr-Jun.

31.

Comment on extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?

Gaitán MI, Correale J.

Mult Scler. 2017 Apr;23(4):617-618. doi: 10.1177/1352458516682859. Epub 2016 Dec 14. No abstract available.

PMID:
28273765
32.

Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis.

Negrotto L, Correale J.

J Immunol. 2017 Mar 1;198(5):1900-1909. doi: 10.4049/jimmunol.1601139. Epub 2017 Jan 27.

33.

Iron Availability Compromises Not Only Oligodendrocytes But Also Astrocytes and Microglial Cells.

Rosato-Siri MV, Marziali L, Guitart ME, Badaracco ME, Puntel M, Pitossi F, Correale J, Pasquini JM.

Mol Neurobiol. 2018 Feb;55(2):1068-1081. doi: 10.1007/s12035-016-0369-2. Epub 2017 Jan 14.

PMID:
28092084
34.

Gender ratio trends over time in multiple sclerosis patients from Argentina.

Rojas JI, Patrucco L, MIguez J, Sinay V, Cassara FP, Cáceres F, Liguori NF, Saladino ML, Deri N, Jaacks G, Marcilla MP, Arrigoni MI, Correale J, Fiol M, Ysrraelit MC, Carrá A, Curbelo MC, Martinez A, Steinberg J, Bestoso S, Hryb JP, Di Pace JL, Perassolo MB, Contentti EC, Caride A, Lopez PA, Martinez C, Reich E, Giunta D, Cristiano E.

J Clin Neurosci. 2017 Apr;38:84-86. doi: 10.1016/j.jocn.2016.12.030. Epub 2017 Jan 10.

PMID:
28087187
35.

Progressive multiple sclerosis: from pathogenic mechanisms to treatment.

Correale J, Gaitán MI, Ysrraelit MC, Fiol MP.

Brain. 2017 Mar 1;140(3):527-546. doi: 10.1093/brain/aww258. Review.

PMID:
27794524
36.

Increasing prevalence of multiple sclerosis in Buenos Aires, Argentina.

Cristiano E, Patrucco L, Miguez J, Giunta D, Correale J, Fiol M, Ysrraelit MC, Cáceres F, Liguori NF, Saladino ML, Garcea O, Silva B, Alonso R, Carrá A, Curbelo MC, Martinez A, Steinberg J, Giachello S, Melcom MO, Rojas JI.

Mult Scler Relat Disord. 2016 Sep;9:91-4. doi: 10.1016/j.msard.2016.07.007. Epub 2016 Jul 9.

PMID:
27645351
37.

People with MS should consume a low-salt diet - YES.

Farez MF, Correale J.

Mult Scler. 2016 Dec;22(14):1777-1779. Epub 2016 Sep 8. No abstract available.

PMID:
27609134
38.

Anti-inflammatory effects of melatonin in multiple sclerosis.

Farez MF, Calandri IL, Correale J, Quintana FJ.

Bioessays. 2016 Oct;38(10):1016-26. doi: 10.1002/bies.201600018. Epub 2016 Aug 26. Review.

PMID:
27561251
39.

Combined effects of transferrin and thyroid hormone during oligodendrogenesis In vitro.

Marziali LN, Correale J, Garcia CI, Pasquini JM.

Glia. 2016 Nov;64(11):1879-91. doi: 10.1002/glia.23029. Epub 2016 Jul 22.

PMID:
27444244
40.

Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod.

Correale J, Chiquete E, Boyko A, Beran RG, Strauch JB, Milojevic S, Frider N.

Drug Des Devel Ther. 2016 Jun 30;10:2109-17. doi: 10.2147/DDDT.S106802. eCollection 2016. Review.

41.

Disease onset in familial and sporadic multiple sclerosis in Argentina.

Rojas JI, Patrucco L, MIguez J, Sinay V, Cassara FP, Cáceres F, Liguori NF, Saladino ML, Deri N, Jaacks G, Marcilla MP, Arrigoni MI, Correale J, Fiol M, Ysrraelit MC, Carrá A, Curbelo MC, Martinez A, Steinberg J, Bestoso S, Hryb JP, Di Pace JL, Perassolo MB, Contentti EC, Caride A, Lopez PA, Martinez C, Reich E, Cristiano E.

Mult Scler Relat Disord. 2016 Mar;6:54-6. doi: 10.1016/j.msard.2016.01.004. Epub 2016 Jan 19.

PMID:
27063623
42.

The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity.

Chan PY, Carrera Silva EA, De Kouchkovsky D, Joannas LD, Hao L, Hu D, Huntsman S, Eng C, Licona-Limón P, Weinstein JS, Herbert DR, Craft JE, Flavell RA, Repetto S, Correale J, Burchard EG, Torgerson DG, Ghosh S, Rothlin CV.

Science. 2016 Apr 1;352(6281):99-103. doi: 10.1126/science.aaf1358.

43.

Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis.

Negrotto L, Farez MF, Correale J.

JAMA Neurol. 2016 May 1;73(5):520-8. doi: 10.1001/jamaneurol.2015.4807.

PMID:
26953870
44.

Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis.

Farez MF, Correale J.

J Neurol Sci. 2016 Feb 15;361:60-5. doi: 10.1016/j.jns.2015.12.022. Epub 2015 Dec 15. Review.

PMID:
26810518
45.

Optimal detection of infratentorial lesions with a combined dual-echo MRI sequence: "PT2".

Gaitán MI, Yañes P, Sati P, Romero C, Reich DS, Correale J.

Mult Scler. 2016 Sep;22(10):1367-70. doi: 10.1177/1352458515615226. Epub 2015 Nov 9.

46.

Ultraviolet radiation, vitamin D and multiple sclerosis.

Lucas RM, Byrne SN, Correale J, Ilschner S, Hart PH.

Neurodegener Dis Manag. 2015 Oct;5(5):413-24. doi: 10.2217/nmt.15.33. Epub 2015 Oct 19. Review.

47.

Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses.

Farez MF, Mascanfroni ID, Méndez-Huergo SP, Yeste A, Murugaiyan G, Garo LP, Balbuena Aguirre ME, Patel B, Ysrraelit MC, Zhu C, Kuchroo VK, Rabinovich GA, Quintana FJ, Correale J.

Cell. 2015 Sep 10;162(6):1338-52. doi: 10.1016/j.cell.2015.08.025.

48.

The Role of Astrocytes in Multiple Sclerosis Progression.

Correale J, Farez MF.

Front Neurol. 2015 Aug 18;6:180. doi: 10.3389/fneur.2015.00180. eCollection 2015. Review.

49.

Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.

Correale J, Flores J, Bonitto JG, Rodríguez CC, Oliveira EM.

Adv Ther. 2015 Jul;32(7):612-25. doi: 10.1007/s12325-015-0226-0. Epub 2015 Jul 14. Review.

50.

A 33-Year Old Man with Cervical Pain.

Riudavets MA, Tallone ML, Correale J, Díaz F, Sevlever G.

Brain Pathol. 2015 Jul;25(4):505-6. doi: 10.1111/bpa.12268. No abstract available.

PMID:
26095592

Supplemental Content

Loading ...
Support Center